Sec Form 13G Filing - Azamian Bobak R. filing for Tarsus Pharmaceuticals Inc. (TARS) - 2022-02-14

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

  Names of Reporting Persons

  Bobak Azamian

  Check the Appropriate Box if a Member of a Group (see instructions)

  (a)  ☐        (b)  ☐

  SEC USE ONLY

  Citizenship or Place of Organization

  United States

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With:

  Sole Voting Power

  1,426,091(1)

  Shared Voting Power

  None.

  Sole Dispositive Power

  1,426,091(1)

  Shared Dispositive Power

  None.

  Aggregate Amount Beneficially Owned by Each Reporting Person

  1,426,091(1)

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)

  ☐

  Percent of Class Represented by Amount in Row 9

  6.8%(1)(2)

  Type of Reporting Person (see instructions)

  IN

Consists of (i) 1,750 shares of Common Stock held directly by Bobak Azamian, Ph.D., M.D. (“Dr. Azamian”) (ii) 1,204,106 shares of Common Stock held by Bobak Azamian as Trustee of the Bobak Azamian Living Trust, established April 16, 2018, and (iii) 220,235 shares of Common Stock issuable upon exercise of options exercisable within 60 days of December 31, 2021 held directly by Dr. Azamian. Dr. Azamian is a trustee the Bobak Azamian Living Trust, established April 16, 2018 and has voting and investment control with respect to these shares.

Based on 20,698,737 shares of Common Stock outstanding as of December 31, 2021, as reported by the Issuer to Dr. Azamian, plus the number of shares of Common Stock issuable upon exercise of options exercisable within 60 days of December 31, 2021 held directly by Dr. Azamian.

Name of Issuer: Tarsus Pharmaceuticals, Inc.

Address of Issuer’s Principal Executive Offices:

Name of Person Filing:

Address of Principal Business Office or, if none, Residence: The address and principal business office of the Reporting Person is:

Citizenship:

Title of Class of Securities: Common Stock, $0.0001 per share.

CUSIP Number: 87650L103

If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

Ownership

Amount beneficially owned:

Percent of class:

Number of shares as to which the person has:

Sole power to vote or to direct the vote

Shared power to vote or to direct the vote

Sole power to dispose or to direct the disposition of

Shared power to dispose or to direct the disposition of

Ownership of 5 Percent or Less of a Class

Ownership of More than 5 Percent on Behalf of Another Person

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Identification and Classification of Members of the Group

Notice of Dissolution of a Group

Certification